Epidemiology of hepatitis C virus infection among injection drug users in China: Systematic review and meta-analysis

被引:120
|
作者
Xia, Xian [1 ]
Luo, Jun [1 ]
Bai, Jianling [1 ]
Yu, Rongbin [1 ]
机构
[1] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, 140,Hanzhong Rd, Nanjing 210029, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
Hepatitis C virus (HCV); Infection; Injection drug users (IDUs); Prevalence; Meta-analysis; Systematic review; China;
D O I
10.1016/j.puhe.2008.01.014
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objectives: Injection drug use (IDU) is the predominant mode of hepatitis C virus (HCV) transmission in China. This paper aims to provide a comprehensive and reliable tabulation of available data on the epidemiological characteristics and risk factors for HCV infection in injection drug users (IDUs) in China to help inform prevention programmes and guide future research. Study design: Data from articles and reports according to pre-defined criteria on HCV infection rates among IDUs of different regions, genders, ethnic backgrounds and risk factors (injecting practice, needle sharing, long duration, sex behaviour and co-infection status) were abstracted and pooled by meta-analysis. A systematic review was constructed based on both pooled data and representative viewpoints. Methods: Ninety-five percent confidence intervals (CI) of infection rates were calculated using the approximate normal distribution model. Odds ratios and 95% Cl were calculated by fixed or random effects models. Publication bias was examined using Begg's test and Egger's test. Data manipulation and statistical analyses were undertaken using STATA 7.0 and RevMan 4.2. Epi Info 3.4.3 was used for map construction. Results: The pooled prevalence of HCV infection among IDUs in China was 61.4% (95% CI 55.7-67.2%), and the epidemic was most severe in Hubei, Yunnan, Guangxi, Hunan and Xinjiang. No significant difference was found in HCV infection rates between mate and female IDUs. A significant association was found between HCV infection and ethnic-minority status. IDUs were 9.24 times more likely to be infected with HCV than non-IDUs, while non-IDUs were more likely to be infected with HCV than members of the general population and other risk populations. There was no significant difference in the risk of HCV infection for needle-sharing IDUs and non-needle-sharing IDUs. A longer duration of IDU was associated with increased HCV prevalence. High-risk sexual practices were strongly associated with drug injection behaviours. Co-infection with human immunodeficiency virus (HIV) greatly increased the probability of HCV infection among IDUs, while the probability of hepatitis B virus infection remained similar for HCV-positive and HCV-negative IDUs in China. Conclusions: IDU continues to fuel the HCV/HIV epidemics spreading throughout China. Many pragmatic strategies are being implemented but need further evaluation. (C) 2008 The Royal Institute of Public Health. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:990 / 1003
页数:14
相关论文
共 50 条
  • [21] The prevalence of hepatitis C virus infection in β-thalassemia patients in Pakistan: a systematic review and meta-analysis
    Akhtar, Sohail
    Nasir, Jamal Abdul
    Hinde, Andrew
    BMC PUBLIC HEALTH, 2020, 20 (01)
  • [22] Epidemiology of hepatitis B virus infection among pregnant women in Africa: a systematic review and meta-analysis
    Wondmeneh, Temesgen Gebeyehu
    Mekonnen, Ayal Tsegaye
    BMC INFECTIOUS DISEASES, 2024, 24 (01)
  • [23] Hepatitis C infection epidemiology in Mongolia: protocol of a systematic review and meta-analysis
    Karima Chaabna
    Laith J. Abu-Raddad
    Systematic Reviews, 6
  • [24] Hepatitis C infection epidemiology in Mongolia: protocol of a systematic review and meta-analysis
    Chaabna, Karima
    Abu-Raddad, Laith J.
    SYSTEMATIC REVIEWS, 2017, 6
  • [25] Prevalence of Hepatitis B and Hepatitis C Virus Co-infection in India: A Systematic Review and Meta-analysis
    Desikan, Prabha
    Khan, Zeba
    INDIAN JOURNAL OF MEDICAL MICROBIOLOGY, 2017, 35 (03) : 332 - 339
  • [26] Efficacy and safety of ledipasvir/sofosbuvir for hepatitis C among drug users: a systematic review and meta-analysis
    Xue Yang
    Yang Tang
    Di Xu
    Guang Zhang
    Peng Xu
    Houlin Tang
    Lin Pang
    Virology Journal, 18
  • [27] Systematic review and, meta-analysis of hepatitis C virus infection in the Democratic Republic of Congo
    Muzembo, B. A.
    Akita, T.
    Matsuoka, T.
    Tanaka, J.
    PUBLIC HEALTH, 2016, 139 : 13 - 21
  • [28] Efficacy and safety of ledipasvir/sofosbuvir for hepatitis C among drug users: a systematic review and meta-analysis
    Yang, Xue
    Tang, Yang
    Xu, Di
    Zhang, Guang
    Xu, Peng
    Tang, Houlin
    Pang, Lin
    VIROLOGY JOURNAL, 2021, 18 (01)
  • [29] Hepatitis B infection in the general population of China: a systematic review and meta-analysis
    Huai Wang
    Peixuan Men
    Yufeng Xiao
    Pei Gao
    Min Lv
    Qianli Yuan
    Weixin Chen
    Shuang Bai
    Jiang Wu
    BMC Infectious Diseases, 19
  • [30] Hepatitis C virus infection and risk of thyroid cancer: A systematic review and meta-analysis
    Wang, Peng
    Jing, Zhaohai
    Liu, Changjiang
    Xu, Meihua
    Wang, Pei
    Wang, Xiao
    Yin, Yulei
    Cui, Ying
    Ren, Dunlin
    Rao, Xiaopang
    ARAB JOURNAL OF GASTROENTEROLOGY, 2017, 18 (01) : 1 - 5